Olive oil and postprandial hyperlipidemia: Implications for atherosclerosis and metabolic syndrome

Food and Function

Volumn 7, Issue 12, 2016, Pages 4734-4744

  Montserrat De La Paz, Sergio ^a   Bermudez, Beatriz ^b   Cardelo, Magdalena P ^a   Lopez, Sergio ^a   Abia, Rocio ^a   Muriana, Francisco J G ^a  

^a INSTITUTO DE LA GRASA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; LIPIDS; LIPOPROTEINS; METABOLISM;

CORE COMPONENTS; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEINS; MEDITERRANEAN DIET; METABOLIC SYNDROMES; PLASMA TRIGLYCERIDES; PRIMARY SOURCES; TYPE-2 DIABETES;

OLIVE OIL;

OLIVE OIL;

ATHEROSCLEROSIS; HUMAN; HYPERGLYCEMIA; MEDITERRANEAN DIET; METABOLIC SYNDROME X;

ATHEROSCLEROSIS; DIET, MEDITERRANEAN; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME; OLIVE OIL;

EID: 85003844992     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c6fo01422d     Document Type: Review

References (88)

1. S. Lopez B. Bermudez S. Montserrat-de la Paz S. Jaramillo R. Abia F. J. Muriana Virgin olive oil and Hypertension Curr. Vasc. Pharmacol. 2016 14 323 329
2. J. M. Ochando-Pulido A. Martinez-Ferez On the recent use of membrane technology for olive mil wastewater purification Membranes 2015 5 513 531
3. B. Bermudez S. Lopez A. Ortega L. M. Varela Y. M. Pacheco R. Abia F. J. Muriana Oleic acid in olive oil: from a metabolic framework toward a clinical perspective Curr. Pharm. Des. 2011 17 831 843
4. A. B. Mansour B. Gargouri G. Flamini M. Bouaziz Effect of agricultural sites on differentiation between Chemlali and Neb Jmel olive oils J. Oleo Sci. 2015 64 381 392
5. A. Cardeno M. Aparicio-Soto S. Montserrat-de la Paz B. Bermudez F. J. G. Muriana C. Alarcon-de-la-Lastra Squalene targets pro- and anti-inflammatory mediators and pathways to modulate over-activation of neutrophils, monocytes and macrophages J. Funct. Foods 2015 14 779 790
6. S. Lopez B. Bermudez S. Montserrat-de la Paz S. Jaramillo L. M. Varela A. Ortega-Gomez R. Abia F. J. Muriana Membrane composition and dynamics: A target of bioactive virgin olive oil constituents Biochim. Biophys. Acta, Biomembr. 2014 1838 1638 1656
7. L. Hodson B. A. Fielding Stearoyl-CoA desaturase: rogue or innocent bystander? Prog. Lipid Res. 2013 52 15 42
8. C. A. De la Lastra An up-date of olive oil and bioactive constituents in health: molecular mechanisms and clinical implications Curr. Pharm. Des. 2011 17 752 753
9. E. Frankel A. Bakhouche J. Lozano-Sanchez A. Segura-Carretero A. Fernandez-Gutierrez Literature review on production process to obtain extra virgin olive oil enriched in bioactive compounds. Potential use of byproducts as alternative sources of polyphenols J. Agric. Food Chem. 2013 61 5179 5188
10. P. J. Tomasik A. Wedrychowicz I. Rogatko A. Zajac K. Fyderek K. Sztefko Gastric lipase secretion in children with gastritis Nutrients 2013 5 2924 2932
11. K. Johnson L. Ross R. Miller X. Xiao M. E. Lowe Pancreatic lipase-related protein 2 digests fats in human milk and formula in concert with gastric lipase and carboxyl ester lipase Pediatr. Res. 2013 74 127 132
12. Y. Pafumi D. Lairon P. L. de la Porte C. Juhel J. Storch M. Hamosh M. Armand Mechanisms of inhibition of triacylglycerol hydrolysis by human gastric lipase J. Biol. Chem. 2002 277 28070 28079
13. D. A. Gross D. L. Silver Cytosolic lipid droplets: from mechanisms of fat storage to disease Crit. Rev. Biochem. Mol. Biol. 2014 49 304 326
14. Y. Gargouri G. Pieroni F. Ferrato R. Verger Human gastric lipase. A kinetic study with dicaprin monolayers Eur. J. Biochem. 1987 169 125 129
15. J. Iqbal M. M. Hussain Intestinal lipid absorption Am. J. Physiol.: Endocrinol. Metab. 2009 296 E1183 E1194
16. S. G. Young R. Zechner Biochemistry and pathophysiology of intravascular and intracellular lipolysis Genes Dev. 2013 27 459 484
17. R. Abia J. S. Perona Y. M. Pacheco E. Montero F. J. G. Muriana V. Ruiz-Gutierrez Postprandial triacylglycerols from dietary virgin olive oil are selectively cleared in humans J. Nutr. 1999 129 2184 2192
18. K. Murota J. Storch Uptake of micellar long-chain fatty acid and sn-2-monoacylglycerol into human intestinal Caco-2 cells exhibits characteristics of protein-mediated transport J. Nutr. 2005 135 1626 1630
19. W. S. Lagakos A. M. Gajda L. Agellon B. Binas V. Choi B. Mandap T. Russnak Y. X. Zhou J. Storch Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis Am. J. Physiol.: Gastrointest. Liver Physiol. 2011 300 G803 G814
20. C. Rohrl H. Stangl HDL endocytosis and resecretion Biochim. Biophys. Acta 2013 1831 1626 1633
21. H. Mu C. E. Hoy The digestion of dietary triacylglycerols Prog. Lipid Res. 2004 43 105 133
22. C. H. Kim J. Park M. Kim Gut microbiota-derived short chain fatty acids, T cells, and inflammation Immune Network 2014 14 277 288
23. F. Wilfling H. Wang J. T. Haas N. Krahmer T. J. Gould A. Uchida J. X. Cheng M. Graham R. Chistiano F. Fröhlich et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from ER to lipid droplets Dev. Cell 2013 24 384 399
24. A. Bysted G. Holmer P. Lund B. Sandstrom T. Tholstrup Effect of dietary fatty acids on the postprandial fatty acid composition of triacylglycerol-rich lipoproteins in healthy male subjects Eur. J. Clin. Nutr. 2005 59 24 34
25. A. Giammanco A. B. Cefalu D. Noto M. R. Averna The pathophysiology of intestinal lipoprotein production Front. Physiol. 2015 6 61
26. B. Bermudez Y. M. Pacheco S. Lopez R. Abia F. G. M. Muriana Digestion and absorption of olive oil Grasas Aceites 2004 55 1 10
27. L. M. Varela A. Ortega-Gomez S. Lopez R. Abia F. J. Muriana B. Bermudez The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells J. Nutr. Biochem. 2013 24 2031 2039
28. S. Montserrat-de la Paz B. Bermudez M. C. Naranjo S. Lopez R. Abia F. J. G. Muriana Pharmacological effects of niacin on acute hyperlipemia Curr. Med. Chem. 2016 25 2826 2835
29. J. S. Cohn Postprandial lipemia and remnant lipoproteins Clin. Lab. Med. 2006 26 773 786
30. D. B. Zilversmit Atherogenesis: a postprandial phenomenon Circulation 1979 60 473 485
31. A. D. Sniderman Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective Eur. J. Clin. Invest. 2000 30 935 937
32. J. R. Patsch G. Miesenbock T. Hopferwieser V. Mühlberger E. Knapp J. K. Dunn A. M. Gotto Jr. W. Patsch Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state Arterioscler. Thromb. 1992 12 1336 1345
33. S. D. Proctor D. F. Vine J. C. Mamo Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis Curr. Opin. Lipidol. 2002 13 461 470
34. A. Pirillo G. D. Norata A. L. Catapano Postprandial lipemia as a cardiometabolic risk factor Curr. Med. Res. Opin. 2014 30 1489 1503
35. M. C. Naranjo I. Garcia B. Bermudez S. Lopez M. P. Cardelo R. Abia F. J. G. Muriana S. Montserrat-de la Paz Acute effects of dietary fatty acids on osteoclastogenesis via RANKL/RANK/OPG system Mol. Nutr. Food Res. 2016 60 2505 2513
36. S. Montserrat-de la Paz M. C. Naranjo B. Bermudez S. Lopez W. Moreda R. Abia F. J. G. Muriana Postprandial dietary fatty acids exert divergent inflammatory responses in retinal-pigmented epithelium cells Food Funct. 2016 7 1345 1353
37. S. Montserrat-de la Paz B. Bermudez S. Lopez M. C. Naranjo Y. Romero M. J. Bando-Hidalgo R. Abia F. J. G. Muriana Exogenous fatty acids and niacin on acute prostaglandin D2 production in human myeloid cells J. Nutr. Biochem. 2017 39 22 31
38. S. Patel R. Puranik S. Nakhla P. Lundman R. Stocker X. S. Wang G. Lambert K. A. Rye P. J. Barter S. J. Nicholls et al., Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins Atherosclerosis 2009 204 424 428
39. A. S. Lindman M. B. Veierod A. Tverdal J. L. Pedersen R. Selmer Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian counties study Eur. J. Epidemiol. 2010 25 789 798
40. J. Boren N. Matikainen M. Adiels M. R. Taskinen Postprandial hypertriglyceridemia as a coronary risk factor Clin. Chim. Acta 2014 431 131 142
41. M. Miller C. P. Cannon S. A. Murphy J. Qin K. K. Ray E. Braunwald Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J. Am. Coll. Cardiol. 2008 51 724 730
42. B. G. Nordestgaard M. Benn P. Schnohr A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women J. Am. Med. Assoc. 2007 298 299 308
43. S. Bansal J. E. Buring N. Rifai S. Mora F. M. Sacks P. M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women J. Am. Med. Assoc. 2007 298 309 316
44. D. Fernandez-Berges A. Cabrera de Leon H. Sanz R. Elosua M. J. Guembe M. Alzamora T. Vega-Alonso F. J. Félix-Redondo H. Ortiz-Marrón F. Rigo et al., Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study Rev. Esp. Cardiol. 2012 65 241 248
45. K. G. M. M. Alberti R. H. Eckel S. M. Grundy P. Z. Zimmet J. I. Cleeman K. A. Donato J. C. Fruchart W. P. James C. M. Loria S. C. Smith Jr. et al., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity Circulation 2009 120 1640 1645
46. K. G. M. M. Alberti P. Zimmet J. Shaw The metabolic syndrome - a new worldwide definition Lancet 2005 366 1059 1062
47. J. K. Olijhoek Y. Van Der Graaf J. D. Banga A. Algra T. J. Rabelink F. L. Visseren The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm Eur. Heart J. 2004 25 342 348
48. S. M. Grundy J. I. Cleeman S. R. Daniels K. A. Donato R. H. Eckel B. A. Franklin D. J. Gordon R. M. Krauss P. J. Savage S. C. Smith Jr. et al., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 2005 112 2735 2752
49. P. W. F. Wilson R. B. D'Agostino H. Parise L. Sullivan J. B. Meigs Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 2005 112 3066 3072
50. S. Montserrat-de la Paz M. C. Naranjo S. Lopez R. Abia F. J. G. Muriana B. Bermudez Olive oil, compared to a saturated dietary fat, has a protective role on atherosclerosis in niacin-treated mice with metabolic syndrome J. Funct. Foods 2016 26 557 564
51. S. Montserrat-de la Paz M. C. Naranjo S. Lopez R. Abia F. J. G. Muriana B. Bermudez Niacin and olive oil promote the skewing to the M2 phenotype in bone marrow-derived macrophages of mice with metabolic syndrome Food Funct. 2016 7 2233 2238
52. K. G. M. M. Alberti P. Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Med. 1998 15 539 553
53. B. Balkau M. A. Charles Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR) Diabetic Med. 1999 16 442 443
54. J. I. Cleeman Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) J. Am. Med. Assoc. 2001 285 2486 2497
55. D. Einhorn G. M. Reaven R. H. Cobin E. Ford O. P. Ganda Y. Handelsman R. Hellman P. S. Jellinger D. Kendall R. M. Krauss et al. American College of Endocrinology position statement on the insulin resistance syndrome Endocr. Pract. 2003 9 237 252
56. J. Kaur A comprehensive review on metabolic syndrome Cardiol. Res. Pract. 2014 2014 943162
57. F. Emanuela M. Grazia de R. Marco L. Maria Paola F. Giorgio B. Marco Inflammation as a Link between Obesity and Metabolic Syndrome J. Nutr. Metab. 2012 2012 476380
58. K. Nakajima Pharmacotherapy of mixed dyslipidemia in the metabolic syndrome Curr. Clin. Pharmacol. 2010 5 133 139
59. T. Nakamura J. E. Obata H. Takano K. Kawabata K. Sano T. Kobayashi D. Fujioka Y. Saito T. Yano K. Kugiyama High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis Atherosclerosis 2009 202 234 240
60. B. G. Nordestgaard A. Langsted J. J. Freiberg Nonfasting hyperlipidemia and cardiovascular disease Curr. Drug Targets 2009 10 328 335
61. B. Enkhmaa Z. Ozturk E. Anuurad L. Berglund Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus Curr. Diabetes Rep. 2010 10 61 69
62. S. Lopez B. Bermudez A. Ortega L. M. Varela Y. M. Pacheco J. Villar R. Abia F. J. Muriana Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations Am. J. Clin. Nutr. 2011 93 494 499
63. S. Lopez B. Bermudez Y. M. Pacheco J. Villar R. Abia F. J. Muriana Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids Am. J. Clin. Nutr. 2008 88 638 644
64. G. S. Hotamisligil N. S. Shargill B. M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 1993 259 87 91
65. N. Halberg I. Wernstedt-Asterholm P. E. Scherer The adipocyte as an endocrine cell Endocrinology and Metabolism Clin. North Am. 2008 37 753 768
66. S. Cinti G. Mitchell G. Barbatelli I. Murano E. Ceresi E. Faloia S. Wang M. Fortier A. S. Greenberg M. S. Obin Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J. Lipid Res. 2005 46 2347 2355
67. P. Trayhurn I. S. Wood Adipokines: inflammation and the pleiotropic role of white adipose tissue Br. J. Nutr. 2004 92 347 355
68. K. Karastergiou V. Mohamed-Ali The autocrine and paracrine roles of adipokines Mol. Cell Endocrinol. 2010 318 69 78
69. B. Wang P. Trayhurn Acute and prolonged effects of TNF-α on the expression and secretion of inflammation related adipokines by human adipocytes differentiated in culture Pflugers Arch. 2006 452 418 427
70. J. B. Prins C. U. Niesler C. M. Winterford N. A. Bright K. Siddle S. O'Rahilly N. I. Walker D. P. Cameron Tumor necrosis factor-α induces apoptosis of human adipose cells Diabetes 1997 46 1939 1944
71. G. S. Hotamisligil P. Peraldi A. Budavari R. Ellis M. F. White B. M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance Science 1996 271 665 668
72. S. Bertoli I. G. Neri C. Trentani C. Ferraris R. De Amicis A. Battezzati P. Veggiotti V. De Giorgis A. Tagliabue Short-term effects of ketogenic diet on anthropometric parameters, body fat distribution, and inflammatory cytokine production in GLUT1 deficiency syndrome Nutrition 2015 31 981 987
73. L. Pietrzyk A. Torres R. Maciejewski K. Torres Obesity and Obese-related Chronic Low-grade Inflammation in Promotion of Colorectal Cancer Development Asian Pac. J. Cancer Prev. 2015 16 4161 4168
74. S. Montserrat-de la Paz M. C. Naranjo S. Lopez R. Abia F. J. G. Muriana B. Bermudez Niacin and its metabolites as master regulators of metabolic syndrome J. Nutr. Biochem. 2017 39 40 47
75. P. Wang C. Y. Miao NAMPT as a therapeutic target against stroke Trends Pharmacol. Sci. 2015 36 891 905
76. B. Halvorsen M. Z. Espeland G. O. Andersen A. Yndestad E. L. Sagen A. Rashidi E. C. Knudsen M. Skjelland K. R. Skagen K. Krohg-Sorensen et al., Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages Atherosclerosis 2015 243 204 210
77. M. Hoene C. Weigert The role of interleukin-6 in insulin resistance, body fat distribution and energy balance Obes. Rev. 2008 9 20 29
78. J. Scheller C. Garbersb S. Rose-John Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities Semin. Immunol. 2014 26 2 12
79. A. Varbo M. Benn A. Tybjaerg-Hansen A. B. Jorgensen R. Frikke-Schmidt B. G. Nordestgaard Remnant cholesterol as a causal risk factor for ischemic heart disease J. Am. Coll. Cardiol. 2013 61 427 436
80. M. Miller N. J. Stone C. Ballantyne V. Bittner M. H. Criqui H. N. Ginsberg A. C. Golberg W. J. Howard M. S. Jacobson P. M. Kris-Etherton et al., Triglycerides and cardiovascular disease Circulation 2011 123 2292 2333
81. A. L. Catapano Z. Reiner G. De Backer I. Graham M. R. Taskinen O. Wiklund S. Agewall E. Alegria M. Chapman P. Durrington et al., ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 2011 217 3 46
82. L. Berglund J. D. Brunzell A. C. Goldberg I. J. Goldberg F. Sacks M. H. Murad A. F. Stalenhoef Endocrine society Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline J. Clin. Endocrinol. Metab. 2012 97 2969 2989
83. G. F. Watts E. M. Ooi D. C. Chan Demystifying the management of hypertriglyceridaemia Nat. Rev. Cardiol. 2013 10 648 661
84. Y. M. Pacheco B. Bermudez S. Lopez R. Abia J. Villar F. J. Muriana Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men Am. J. Clin. Nutr. 2006 84 342 349
85. T. F. Members L. Ryden P. J. Grant S. D. Anker C. Berne F. Cosentino N. Danchin C. Deaton J. Escaned H. P. Hammes et al., ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) Eur. Heart J. 2013 34 3035 3087
86. G. D. Kolovou D. P. Mikhailidis J. Kovar D. Lairon B. G. Nordestgaard T. C. Ooi P. Perez-Martinez H. Bilianou K. Anagnostopoulou G. Panotopoulos Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement Curr. Vasc. Pharmacol. 2011 9 258 270
87. A. J. Tremblay B. Lamarche J. C. Hogue P. Couture Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia J. Lipid Res. 2009 50 1463 1471
88. D. C. Chan A. T. Wong S. Yamashita G. F. Watts Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment Atherosclerosis 2012 221 484 489